Compare WKHS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKHS | MYO |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3M | 33.3M |
| IPO Year | 2008 | 2017 |
| Metric | WKHS | MYO |
|---|---|---|
| Price | $2.99 | $1.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $21.00 | $7.67 |
| AVG Volume (30 Days) | 170.7K | ★ 952.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $1,000,000,000.00 |
| Revenue This Year | $89.23 | $9.10 |
| Revenue Next Year | $28.84 | $13.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $0.53 | $0.61 |
| 52 Week High | $11.80 | $2.89 |
| Indicator | WKHS | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 53.82 |
| Support Level | $2.81 | $0.71 |
| Resistance Level | $4.18 | N/A |
| Average True Range (ATR) | 0.37 | 0.16 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 3.75 | 34.13 |
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.